You are here

• Home
• Total number of clinical trials

• A Phase I Randomised, Placebo-Controlled, Double-Blind Study in Hypertensive Patients of the Blood Pressure Interaction between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors)

Disease

pharmacokinetics

Drug Name

TC-5214

Generic Name

TC-5214

Sponsor

AstraZeneca

Drug Status

In Development

Phase

I

Start Date

Jan 18, 1971

Study Name

D4130C00010

Study Id

D4130C00010

ClinicalTrials.gov ID

NCT01403922

Recruiting Status

Closed

Protocol Status

Not Available

Report

Apr 17, 2013

• D4130C00010.pdf (302 KB)

Page tools

• Print
• Bookmark this page